Lung Cancers Today Videos
Advertisement
Dr. Paz-Ares shares his insights on the study's results and the remaining questions about ADCs in lung cancer treatment.
The CheckMate 9LA study evaluated first-line nivolumab plus ipilimumab with 2 cycles of platinum-doublet chemotherapy.
A researcher discusses the implications of identifying potentially pathogenic bacteria in adenocarcinoma tumors.
Valsamo Anagnostou, MD, PhD, discusses advances in the field and her lab's research on the topic.
Dr. Spigel speaks about how the American Society of Clinical Oncology Annual Meeting inspires collaboration and discovery.
Narjust Florez, MD, FASCO, discusses her research on the unique needs of young patients with lung cancer.
Laila Gharzai, MD, discusses her research on the financial impacts of lung biomarker testing.
Dr. Singhi discusses practice-changing data and historic advancements in lung cancer.
Dr. Mehta discusses the study, which met its primary end point, and future directions for the research.
Samantha Armstrong, MD, and Karine Tawagi, MD, discuss the interview on the groundbreaking plenary presentation.
Dr. Halmos hopes to see lung-focused updates take center stage again at next year's annual meeting.
Dr. Manochakian discusses the implications of recent phase 3 trials in lung cancer.
Dr. Florez speaks about her presentation titled "Excluded, Forgotten, and Understudied: The Reality of Lung Cancer in Women."
Dr. Manochakian discusses the most pressing unanswered questions in lung cancer and how they could be addressed.
Dr. Manochakian reflects on progress in lung cancer treatment and why it's critical to bring it to the community setting.
The phase 2 trial evaluated subcutaneous amivantamab and lazertinib as a first-line therapy for EGFR-mutated NSCLC.
Dr. Manochakian shared his insights during the Oncology Brothers Advancements in Oncology event.
Dr. Ugurlu said the event was an inspiring experience that helped him navigate the latest data in oncology.
Dr. Spigel discusses the implications of ADRIATIC at the 2024 American Society of Clinical Oncology Annual Meeting.
Dr. Halmos discusses how the Advancements in Oncology event helped unpack the new data for community oncologists.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.